Skip to main content

EFSA update on TSE in sheep

The Community Reference Laboratory (CRL) has notified the European Commission (EC) of the results of a second level of testing for Transmissible Capable of being passed between individuals in the same species, as well as between different species (e.g. from animals to humans). Spongiform Encephalopathy (TSE)[1] of samples from one sheep from Cyprus and two sheep from France. Although a second level of testing could not classify any of the samples conclusively as BSE in sheep, there is insufficient evidence to definitively rule out the presence of BSE. Therefore, a more comprehensive third test will now be carried out consisting of a 12-18 month mouse bioassay A standard way of measuring how a substance (e.g. a vitamin, hormone or fertiliser) has affected an organism or a tissue within that organism. in order to determine the types of TSE in question.

EFSA’s Scientific Experts and its Panel on Biological Hazards (BIOHAZ) will be meeting during the week beginning 13th March and will review the relevant scientific data and address relevant questions in relation to the CRL results. In addition, EFSA is proceeding with its ongoing preparation of a quantitative risk assessment A specialised field of applied science that involves reviewing scientific data and studies in order to evaluate risks associated with certain hazards. It involves four steps: hazard identification, hazard characterisation, exposure assessment and risk characterisation. of the BSE risk associated with sheep products. This assessment will be ready towards autumn 2006.

[1] TSE = Transmissible Spongiform Encephalopathy: A family of transmissible progressive diseases that mainly affects the central nervous system characterized by spongiform degeneration and a long incubation period. Examples of TSEs are Creutzfeldt-Jakob Disease (CJD) and kuru in humans, scrapie in small ruminants and Bovine Spongiform Encephalopathy (BSE) in bovines.
 

How to contact us

EFSA Media Relations Office

Tel. +39 0521 036 149

E-mail: press [at] efsa.europa.eu (Press[at]efsa[dot]europa[dot]eu)

(Only if you are a member of the press)

Ask a Question Service

You have a question about EFSA’s work? Contact our Ask a Question service!

Ask a Question Service